Ontipria (Tiotropium Bromide)

Tiotropium bromide, the active ingredient in Ontipria, is a long-acting muscarinic antagonist presented as a inhalation powder for oral inhalation use. It is indicated for maintenance therapy in chronic obstructive pulmonary disease, including emphysema and chronic bronchitis, in adults. GNH USA supplies Ontipria as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Ontipria as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ontipria is a bronchodilator that works by targeting the cholinergic pathway of the respiratory system to relieve air flow obstruction and improve lung function among patients with chronic COPD and related conditions:

- Chronic COPD: improves the duration of bronchodilation and reduces symptom frequency in stable COPD. - Emphysema and chronic bronch b ​​  ​  ​  … -  …  … ... ...  … … … …  -  ....  .... .... … … … ... … … … … … … … … … … ... ... …  …  …  ....